# US 2021/0062347 A1 · Composition and method for creating nanoscale surface geometry on a cobalt chromium implantable device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0062347 A1
- Document ID: US20210062347A1
- Status: Published application
- Kind: A1
- Application number: 17/005,884
- Filed: 2020-08-28
- Published: 2021-03-04
- Earliest claimed: 2019-08-29
- Assignees: Tech Met, Inc.
- Applicants: Tech Met, Inc.
- Inventors: Michael Vidra; Jordan Incerpi; Daniel Jon Schutzer
- Web page: https://patentgrep.com/patent/US20210062347A1

## CPC

- C23F 1/26: for etching refractory metals
- C23F 1/28: for etching iron group metals
- A61F 2/30767: {Special external or bone-contacting surface, e.g. coating for improving bone ingrowth}
- A61F 2/3094: {Designing or manufacturing processes}
- A61L 27/045: {Cobalt or cobalt alloys}
- A61L 31/022: {Metals or alloys}
- C25F 3/02: Etching
- C25F 3/08: of refractory metals
- A61F 2002/3084: {Nanostructures}
- A61F 2002/30925: {etched}
- A61F 2002/3093: {for promoting ingrowth of bone tissue}
- A61F 2002/30985: {using three dimensional printing [3DP]}
- A61F 2310/00029: Cobalt-based alloys, e.g. Co-Cr alloys or Vitallium
- A61F 2310/00329: Glasses, e.g. bioglass
- A61L 2400/18: Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
- B82Y 5/00: Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- B82Y 30/00: Nanotechnology for materials or surface science, e.g. nanocomposites
- B82Y 40/00: Manufacture or treatment of nanostructures
- C23F: NON-MECHANICAL REMOVAL OF METALLIC MATERIAL FROM SURFACE (working metal by laser beams B23K26/00; desurfacing by applying flames B23K7/00; working of metal by electro-erosion B23H; producing decorative effects by removing surface material, e.g. by engraving, by etching, B44C1/22; electrolytic etching or polishing C25F); INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL; MULTI-STEP PROCESSES FOR SURFACE TREATMENT OF METALLIC MATERIAL INVOLVING AT LEAST ONE PROCESS PROVIDED FOR IN CLASS C23 AND AT LEAST ONE PROCESS COVERED BY SUBCLASS C21D OR C22F OR CLASS C25
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C25F: PROCESSES FOR THE ELECTROLYTIC REMOVAL OF MATERIALS FROM OBJECTS; APPARATUS THEREFOR
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES

## Abstract

Compositions and methods for etching an implantable device having a cobalt chrome surface are disclosed. The compositions generally include at least two mineral acids, iron (Fe), and certain component metals of the cobalt chrome to be etched. For example, when etching a cobalt chromium molybdenum alloy, the metals may include chromium (Cr), molybdenum (Mo), and optionally, cobalt (Co). The at least two mineral acids may include hydrochloric acid (HCl), nitric acid (HNO3), and hydrofluoric acid (HF). Alternatively, the composition may be an electrolyte composition useful for electrochemical etching of the implantable device. These compositions and methods may generate nanoscale geometry on the surface of the implantable device to provide implants with improved osseointegration, biocompatibility, and healing after surgery.

## Claims

### Claim 1

A composition for etching a nanoscale surface geometry into a cobalt chromium surface of a body implantable device, the composition comprising:
at least two mineral acids selected from the groups consisting of hydrochloric acid (HCl), nitric acid (HNO3), sulfuric acid (H2SO4), and hydrofluoric acid (HF); and
component metals of the cobalt chromium alloy,
wherein the body implantable device is a bone-contacting device and the nanoscale surface geometry enhances osseointegration when the bone-contacting device is implanted adjacent living bone, or
wherein the body implantable device is a tissue-contacting device and the nanoscale surface geometry enhances endothelial attachment and proliferation when the tissue-contacting device is implanted adjacent tissue.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the at least two mineral acids comprise hydrochloric acid (HCl), nitric acid (HNO3), and hydrofluoric acid (HF).

### Claim 3 (depends on 2)

The composition of claim 2, comprising:
2N-10N hydrochloric acid (HCl);
05N-0.8N nitric acid (HNO3); and
0.6N-1.3N hydrofluoric acid (HF).

### Claim 4 (depends on 1)

The composition of claim 1, wherein the component metals comprise:
3-170 g/l chromium (Cr); and
1-40 g/l molybdenum (Mo).

### Claim 5 (depends on 4)

The composition of claim 4, further comprising:
1-300 g/l iron (Fe).

### Claim 6 (depends on 4)

The composition of claim 4, further comprising:
7-355 g/l cobalt (Co).

### Claim 7 (depends on 1)

The composition of claim 1, wherein the component metals comprise Co, Cr, and Mo provided in a native ratio of each metal in the cobalt chromium alloy to be etched.

### Claim 8 (depends on 7)

The composition of claim 7, comprising 60 g/l-180 g/l total of Co, Cr, and Mo.

### Claim 9 (depends on 8)

The composition of claim 8, further comprising 10 g/l-100 g/l Fe.

### Claim 10 (depends on 1)

The composition of claim 1, wherein the composition is an aqueous composition comprising:
2N-10N hydrochloric acid (HCl);
0.05N-0.8N nitric acid (HNO3);
0.6N-1.3N hydrofluoric acid (HF);
7-355 g/l cobalt (Co);
3-170 g/l chromium (Cr); and
1-40 g/l molybdenum (Mo).

### Claim 11 (depends on 10)

The composition of claim 10, further comprising 10 g/l-100 g/l Fe.

### Claim 12 (depends on 1)

A method for etching a nanoscale surface geometry on at least a portion of a cobalt chrome surface of a body implantable device, the method comprising:
preparing a chemical etching composition according to claim 1; and
contacting at least a portion of the cobalt chromium surface of the implantable device with the chemical etching composition.

### Claim 13 (depends on 12)

The method of claim 12, wherein the step of contacting with the chemical etching composition is performed at a reaction temperature of from about 20° C. to about 100° C.

### Claim 14 (depends on 12)

The method of claim 12, wherein the step of contacting with the chemical etching composition is performed at a reaction temperature of from about 82° C. to about 95° C., wherein the composition etches the surface at a rate of 0.1 to 1.0 mil/minute.

### Claim 15 (depends on 12)

The method of claim 12, further comprising, before the step of contacting with the chemical etching composition:
activating the cobalt chromium surface to be etched with an activation solution comprising a 10% to 100% (v/v) aqueous solution of a mineral acid.

### Claim 16 (depends on 15)

The method of claim 15, wherein the activating is carried out within 120 seconds before the contacting.

### Claim 17 (depends on 15)

The method of claim 15, wherein the concentrated mineral acid is a 10% to 100% aqueous solution of hydrochloric acid (v/v).

### Claim 18 (depends on 12)

The method of claim 12, wherein the body implantable device is an implantable bone-contacting device, and wherein the nanoscale surface geometry enhances osseointegration when the bone-contacting device is implanted adjacent living bone.

### Claim 19 (depends on 12)

The method of claim 12, wherein the body implantable device is an implantable tissue-contacting device, and the nanoscale surface geometry enhances endothelial attachment and proliferation when the tissue-contacting device is implanted adjacent tissue.

### Claim 20

A method for etching a nanoscale geometry into at least a portion of a cobalt chromium surface of a body implantable device, the method comprising:
submersing at least the portion of the cobalt chromium surface of the body implantable device in an aqueous electrolyte solution, wherein the aqueous electrolyte solution comprises 0.01M to 10M of one or more metal salts, wherein the one or more metal salts are selected from the group comprising NaBr, NaCl, NaF, NaNO3, NaF, KBr, KCl, and KF; and
passing an electric current of 5 Amps/in2 to 100 Amps/in2 through the electrolyte solution between a cathode and an anode, wherein the implantable device acts as the anode or is attached to the anode,
wherein the body implantable device is a bone-contacting device and the nanoscale surface geometry enhances osseointegration when the bone-contacting device is implanted adjacent living bone, or
wherein the body implantable device is a tissue-contacting device and the nanoscale surface geometry enhances endothelial attachment and proliferation when the tissue-contacting device is implanted adjacent tissue.
